These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Preparatory techniques of fluids and screening of malignant cells in effusions]. Nagumo S Rinsho Byori; 1990 Nov; Suppl 87():191-200. PubMed ID: 2287088 [No Abstract] [Full Text] [Related]
4. Malignant effusions and their management. Zehner LC; Hoogstraten B Semin Oncol Nurs; 1985 Nov; 1(4):259-68. PubMed ID: 3854237 [No Abstract] [Full Text] [Related]
5. [Long-time results of intracavitary isotope therapy of malignant effusions]. Lang T; Riccabona G Nucl Med (Stuttg); 1974 Nov; 13(3):245-51. PubMed ID: 4141497 [No Abstract] [Full Text] [Related]
6. A study on acidic mucopolysaccharides in pleural and pericardial effusions and in ascites. Arai H Sci Rep Res Inst Tohoku Univ Med; 1972 Jul; 19(1):26-37. PubMed ID: 4265355 [No Abstract] [Full Text] [Related]
7. The effect of malignant effusions on methotrexate disposition. Li J; Gwilt P Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of malignant effusions in body cavities]. Hentrich M; Hartenstein R Internist (Berl); 1997 Aug; 38(8):794-804. PubMed ID: 9378629 [No Abstract] [Full Text] [Related]
10. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey. Hallman JR; Geisinger KR Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212 [TBL] [Abstract][Full Text] [Related]
11. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort. Roberts JE; Bezack BJ; Winger DI; Pollack S; Shah RA; Cataletto M; Katz DS; Montoya-Iraheta C; Schroeder SA; Quintos-Alagheband ML Pediatrics; 2008 Dec; 122(6):e1231-5. PubMed ID: 18984649 [TBL] [Abstract][Full Text] [Related]
12. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions]. Ohtani H Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770 [No Abstract] [Full Text] [Related]
13. Diagnostic value of p53 protein in the study of serous effusions. Zoppi JA; Pellicer EM; Sundblad AS Acta Cytol; 1995; 39(4):721-4. PubMed ID: 7631546 [TBL] [Abstract][Full Text] [Related]
14. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related]
15. Critical analysis of the control of malignant effusions with radioisotopes. O'Bryan RM; Talley RW; Brennan MJ; San Diego E Henry Ford Hosp Med J; 1968; 16(1):3-14. PubMed ID: 5642782 [No Abstract] [Full Text] [Related]
16. [Usefulness of AgNOR technique in the interpretation of serous effusions]. Rocher AE; Blanco AM; Palaoro LA Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500 [TBL] [Abstract][Full Text] [Related]
17. [Intrapleural and intraperitoneal instillation of nitrogen mustard in palliative treatment of malignant effusions]. Jordan E; Karnicka-Mlodkowska H Pol Tyg Lek; 1971 May; 26(18):676-8. PubMed ID: 4103813 [No Abstract] [Full Text] [Related]
18. Cytological diagnosis of serous effusions in a cancer hospital in Brazil. Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447 [TBL] [Abstract][Full Text] [Related]
19. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306 [TBL] [Abstract][Full Text] [Related]
20. The lactate dehydrogenases in malignant and non-malignant diseases. Oladipo OO; Ajala MO; Afonja OA Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]